Titre:
  • Hepatitis C virus dynamics among intravenous drug users suggest that an annual treatment uptake above 10% would eliminate the disease by 2030.
Auteur:Bruggmann, Philip; Blach, Sarah; Deltenre, Pierre; Fehr, Jan; Kouyos, Roger; Lavanchy, Daniel; Müllhaupt, Beat; Rauch, Andri; Razavi, Homie; Schmid, Patrick; Semela, David; Stoeckle, Marcel; Negro, Franco
Informations sur la publication:Schweizerische Medizinische Wochenschrift, 147, page (w14543)
Statut de publication:Publié, 2017
Sujet CREF:Sciences bio-médicales et agricoles
MeSH keywords:Antiviral Agents -- therapeutic use
Drug Users -- statistics & numerical data
Harm Reduction
Hepacivirus -- drug effects
Hepatitis C, Chronic -- drug therapy -- epidemiology -- transmission
Humans
Incidence
Models, Statistical
Prevalence
Substance Abuse, Intravenous -- epidemiology
Switzerland -- epidemiology
Langue:Anglais
Identificateurs:urn:issn:0036-7672
info:doi/10.4414/smw.2017.14543
info:pii/smw-14543
info:pmid/29120012